Skin manifestations of rheumatoid arthritis: A study of 215 Turkish patients

International Journal of Dermatology

Volumn 47, Issue 9, 2008, Pages 894-902

  Ergun, Tulin ^a   Inanc, Nevsun ^a   Tuney, Davut ^a   Kotiloglu, Esin Karaa ^a   Seckin, Dilek ^a   Tetik, Cihangir ^a   Direskeneli, Haner ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BURSITIS; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DERMATITIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EARLY INTERVENTION; ECHOGRAPHY; FEMALE; GRANULOMATOUS SKIN DISEASE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAPULE; PATIENT CARE; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SENSITIVITY AND SPECIFICITY; SKIN MANIFESTATION; SYNOVITIS; TURKEY (REPUBLIC); VASCULITIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOPSY, NEEDLE; COHORT STUDIES; COMORBIDITY; DERMATITIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RHEUMATOID NODULE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SKIN DISEASES; SKIN DISEASES, VASCULAR; SKIN ULCER; TURKEY; YOUNG ADULT;

EID: 50149116349     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03708.x     Document Type: Article

References (45)

1. Matteson EL. Extra-articular features of rheumatoid arthritis and systemic involvement. In: Hochberg MC, Silman AJ, Smolen JS, et al., eds. Rheumatology. London: Mosby, 2003: 781-792.
2. Wollheim FA. Rheumatoid arthritis - the clinical picture. In. Maddison PJ, Isenberg DA, Woo P, et al., eds. Oxford Textbook of Rheumatology. Oxford: Oxford University Press, 1998: 1004-1031.
3. Cimmino MA, Salvarani C, Macchioni P, et al. Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int 2000; 19: 213-217.
4. Drosos AA, Lanchbury JS, Panayi GS, et al. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiological, and serologic study. Arthritis Rheum 1992; 35: 745-748.
5. Salvarani C, Macchioni P, Mantovani W, et al. Extraarticular manifestations of rheumatoid arthritis and HLA antigens in northern Italy. J Rheumatol 1992; 19: 242-246.
6. Vlak T. Incidence of rheumatoid nodule in Dalmatia: Similarities and differences among populations. Arch Med Res 2003; 34: 56-59.
7. Carmona L, Gonzalez-Alvaro I, Balsa A, et al. Rheumatoid arthritis in Spain: Occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis 2003; 62: 897-900.
8. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002; 46: 328-346.
9. Klareskog L, van der Heijde de Jager JP. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomised controlled trial. Lancet 2004; 363: 675-681.
10. Maini RN, Breedveld FC, Kalden JR, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 2004; 50: 1051-1065.
11. Bukhari MA, Wiles NJ, Lunt M, et al. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception study. Arthritis Rheum 2003; 48: 46-53.
12. Turesson C, O'Fallon WM, Crowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: Incidence trends and risk factors over 46 years. Ann Rheum Dis 2003; 62: 722-727.
13. Magro CM, Crowson AN. The spectrum of cutaneous lesions in rheumatoid arthritis. A clinical and pathological study of 43 patients. J Cutan Pathol 2003; 30: 1-10.
14. Sayah A, English JC. Rheumatoid arthritis: A review of the cutaneous manifestations. J Am Acad Dermatol 2005; 53: 191-209.
15. Chu P, Connolly MK, LeBoit PE. The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol 1994; 130: 1278-1283.
16. Verneuil L, Dompmartin A, Comoz F, et al. Interstitial granulomatous dermatitis with cutaneous cords and arthritis: A disorder associated with autoantibodies. J Am Acad Dermatol 2001; 45: 286-291.
17. Long D, Thiboutot DM, Majeski JT, et al. Interstitial granulomatous dermatitis with arthritis. J Am Acad Dermatol 1996; 34: 957-961.
18. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
19. Ziff M. The rheumatoid nodule. Arthritis Rheum 1990; 33: 761-767.
20. Veys EM, De Keyser F. Rheumatoid nodules: Differential diagnosis and immunohistological findings. Ann Rheum Dis 1993; 52: 625-626.
21. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: A population-based analysis of trends over 40 years. Arthritis Rheum 2003; 48: 54-58.
22. Chehata JC, Hassell AB, Clarke SA, et al. Mortality in rheumatoid arthritis: Relationship to single and composite measures of disease activity. Rheumatology (Oxford) 2001; 40: 447-452.
23. Nell VP, Machold KP, Eberl G, et al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2004; 43: 906-914.
24. Nalbant S, Corominas H, Hsu B, et al. Ultrasonography for assessment of subcutaneous nodules. J Rheumatol 2003; 30: 1191-1195.
25. Kerstens PJ, Boerbooms AM, Jeurissen ME, et al. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases. J Rheumatol 1992; 19: 867-871.
26. Thompson RN. Is the appearance of rheumatoid nodules in a rheumatoid patient well controlled on methotrexate an indication to stop the drug? Br J Rheumatol 1992; 31: 86.
27. Combe B, Guttierrez M, Anaya JM, et al. Possible efficacy of hydroxychloroquine on accelerated nodulosis during methotrexate therapy for rheumatoid arthritis. J Rheumatol 1993; 20: 755-756.
28. Abraham Z, Rozenbaum M, Rosner I. Colchicine therapy for low-dose-methotrexate-induced accelerated nodulosis in a rheumatoid arthritis patient. J Dermatol 1999; 26: 691-694.
29. Dash S, Seibold JR, Tiku ML. Successful treatment of methotrexate induced nodulosis with d -penicillamine. J Rheumatol 1999; 26: 1396-1399.
30. Turesson C, O'Fallon WM, Crowson CS, et al. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002; 29: 62-67.
31. Chen KR, Toyohara A, Suzuki A, et al. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J Dermatol 2002; 147: 905-913.
32. Voskuyl AE, Zwinderman AH, Westedt ML, et al. The mortality of rheumatoid vasculitis compared with rheumatoid arthritis. Arthritis Rheum 1996; 39: 266-271.
33. Bywaters EG. Peripheral vascular obstruction in rheumatoid arthritis and its relationships to other vascular lesions. Ann Rheum Dis 1957; 16: 84-103.
34. Öien RF, Hakansson A, Hansen BU. Leg ulcers in patients with rheumatoid arthritis - a prospective study of aetiology, wound healing and pain reduction after pinch grafting. Rheumatology (Oxford) 2001; 40: 816-820.
35. Aloi F, Tomasini C, Pippione M. Interstitial granulomatous dermatitis with plaques. Am J Dermatopathol 1999; 21: 320-323.
36. Scherbenske JM, Benson PM, Lupton GP, et al. Rheumatoid neutrophilic dermatitis. Arch Dermatol 1989; 125: 1105-1108.
37. Higaki Y, Yamashita H, Sato K, et al. Rheumatoid papules: A report on four patients with histopathologic analysis. J Am Acad Dermatol 1993; 28: 406-411.
38. Finan MC, Winkelmann RK. The cutaneous extravascular necrotizing granuloma (Churg-Strauss Granuloma) and systemic disease. a review of 27 cases. Medicine (Baltimore) 1983; 62: 142-158.
39. Finan MC. Rheumatoid papule, cutaneous extravascular necrotizing granuloma, and Churg-Strauss granuloma: Are they the same entity? J Am Acad Dermatol 1990; 22: 142-143.
40. Patterson JW. Rheumatoid nodule and subcutaneous granuloma annulare: A comparative histologic study. Am J Dermatopathol 1988; 10: 1-8.
41. Sangueza OP, Caudell MD, Mengesha YM, et al. Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol 2002; 47: 251-257.
42. Goerttler E, Kutzner H, Peter HH, et al. Methotrexate-induced papular eruption in patients with rheumatic diseases: A distinctive adverse cutaneous reaction produced by methotrexate in patients with collagen vascular diseases. J Am Acad Dermatol 1999; 40: 702-707.
43. Yu GV, Farrer AK. Benign rheumatoid nodule versus subcutaneous granuloma annulare: A diagnostic dilemma -are they the same entity? J Foot Ankle Surg 1994; 33: 156-166.
44. Imeryuz N, Yazici H, Kocak H, et al. Pericardial and pulmonary involvement in rheumatoid arthritis in Turkey. Clin Rheumatol 1994; 13: 239-243.
45. Istanbul Rheumatology Study Group and Saruhan-Direskeneli G. Shared epitope "homozygosity" is strongly associated with rheumatoid arthritis in Turkey. Br J Rheumatol 1998; 37: 1126-1128.